Vivek Ramaswamy is an entrepreneur and businessperson who founded Roivant Sciences GmbH, Roivant Sciences, Inc., Campus Venture Network, Inc. and Roivant Sciences Ltd. and who has been the head of 10 different companies. Presently, Mr. Ramaswamy is Executive Chairman for Roivant Sciences Ltd., Executive Chairman of Roivant Sciences GmbH and Executive Chairman at Roivant Sciences, Inc. (both are subsidiaries of Roivant Sciences Ltd.) and Chairman of Montes Archimedes Acquisition Corp. Mr. Ramaswamy is also on the board of Sumitovant Biopharma, Inc. In his past career Mr. Ramaswamy was Chairman at Arbutus Biopharma Corp. and Chairman at Arbutus Biopharma, Inc. (a subsidiary of Arbutus Biopharma Corp.), Director at Sio Gene Therapies, Inc. and Chief Executive Officer at Axovant Sciences, Inc. (a subsidiary of Sio Gene Therapies, Inc.), President of Campus Venture Network, Inc., Investment Analyst at QVT Financial LP and Director at Myovant Sciences Ltd. He received a graduate degree from Yale Law School and an undergraduate degree from Harvard College.

Linked companies

Strive Asset Management LLC Strive Asset Management LLC Investment ManagersFinance The company, co-founded by Vivek Ramaswamy and Anson Frericks in 2022, is based in Dublin, OH. Part of Strive Enterprises, Inc., Strive Asset Management LLC is a US-based asset management firm that aims to restore the voices of everyday citizens in the American economy by leading companies to prioritize excellence over politics. Strive Asset Management LLC plans to compete with the world's largest asset managers by launching index funds that promote excellence capitalism across corporate sectors. Matthew Cole has been the CEO of the company since 2022.

Chairman